The Oncology Partnering Terms
and Agreements report provides comprehensive understanding and unprecedented
access to the oncology partnering deals and agreements entered into by the
worlds leading healthcare companies.
The report provides a
detailed understanding and analysis of how and why companies enter oncology
partnering deals. The majority of deals are discovery or development stage
whereby the licensee obtains a right or an option right to license the
licensors oncology technology. These deals tend to be multicomponent, starting
with collaborative R&D, and commercialization of outcomes.
Request
a Sample for or Inquire before buying the report@
Oncology
Partnering Terms and Agreements
Understanding the flexibility
of a prospective partner’s negotiated deals terms provides critical insight
into the negotiation process in terms of what you can expect to achieve during
the negotiation of terms. Whilst many smaller companies will be seeking details
of the payments clauses, the devil is in the detail in terms of how payments
are triggered – contract documents provide this insight where press releases do
not.
This report contains over
2,700 links to online copies of actual oncology deals and contract documents as
submitted to the Securities Exchange Commission by companies and their
partners. Contract documents provide the answers to numerous questions about a
prospective partner’s flexibility on a wide range of important issues, many of
which will have a significant impact on each party’s ability to derive value
from the deal.
Oncology Partnering Terms
and Agreements includes:
·
Trends in oncology dealmaking in the biopharma industry since 2007
·
Analysis of oncology deal structure
·
Access to headline, upfront, milestone and royalty data
·
Case studies of real-life oncology deals
·
Access to over 2,700 oncology contract documents
·
The leading oncology deals by value since 2007
·
Most active oncology dealmakers since 2007
·
The leading oncology partnering resources
Major points covered in Table of Contents of this report
include:
Executive Summary
Executive Summary
Introduction
Trends in oncology dealmaking
Leading oncology deals
Leading oncology deals
Bigpharma oncology deals
Dealmaking directory
Partnering resource center
See More Healthcare Market Research Reports
Report Details :
Published: February 2012
No. of Pages:
Price: Single User License - US $ 2995
No comments:
Post a Comment